Carlo Tur

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

Journal: Annals of the rheumatic diseases

Published: December 19, 2025

BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease.

BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease.

Journal: The New England journal of medicine

Published: October 15, 2025

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

Journal: Nature medicine

Published: September 30, 2025

Reply to Correspondence on: 'Effects of different B-cell-depleting strategies on the lymphatic tissue'.

Reply to Correspondence on: 'Effects of different B-cell-depleting strategies on the lymphatic tissue'.

Journal: Annals of the rheumatic diseases

Published: September 15, 2025

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells.

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells.

Journal: Nature communications

Published: July 17, 2025

Effects of different B-cell-depleting strategies on the lymphatic tissue.

Effects of different B-cell-depleting strategies on the lymphatic tissue.

Journal: Annals of the rheumatic diseases

Published: March 25, 2025

Response to the correspondence on "CD19-CAR T-cell therapy induces deep tissue depletion of B cells".

Response to the correspondence on "CD19-CAR T-cell therapy induces deep tissue depletion of B cells".

Journal: Annals of the rheumatic diseases

Published: March 13, 2025

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells.

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells.

Journal: Nature medicine

Published: January 11, 2025

Minimally invasive ultrasound-guided biopsy of the common extensor tendon enthesis: a cadaveric study to standardise the technique.

Minimally invasive ultrasound-guided biopsy of the common extensor tendon enthesis: a cadaveric study to standardise the technique.

Journal: RMD open

Published: December 05, 2024

Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages.

Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages.

Journal: Annals of the rheumatic diseases

Published: October 28, 2024

BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.

BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.

Journal: The New England journal of medicine

Published: September 04, 2024

CD19-CAR T-cell therapy induces deep tissue depletion of B cells.

CD19-CAR T-cell therapy induces deep tissue depletion of B cells.

Journal: Annals of the rheumatic diseases

Published: May 21, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026